| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2009 | US20090018074 Peptides for Inhibiting Insects |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018071 Epididymis-specific receptor protein |
| 01/15/2009 | US20090018070 Fsh Mutants |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018067 Regulatory t cell epitopes, compositions and uses thereof |
| 01/15/2009 | US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 01/15/2009 | US20090018059 Method for maintaining pluripotency of stem/progenitor cells |
| 01/15/2009 | US20090018032 Method of treating surface of substrate used in biological reaction system |
| 01/15/2009 | US20090018030 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 01/15/2009 | US20090018016 Bacterial glutamine synthetases and methods of use |
| 01/15/2009 | US20090017557 FVII Specific Antibodies and Use Thereof |
| 01/15/2009 | US20090017543 Viral Vectors |
| 01/15/2009 | US20090017542 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy |
| 01/15/2009 | US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences |
| 01/15/2009 | US20090017536 Modified vaccinia ankara virus variant and cultivation method |
| 01/15/2009 | US20090017534 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 01/15/2009 | US20090017533 Optimized messenger rna |
| 01/15/2009 | US20090017532 Vector |
| 01/15/2009 | US20090017531 Method for isolating plasmids from suspended bacterial or yeast cells |
| 01/15/2009 | US20090017530 Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017521 Chimaeric phages |
| 01/15/2009 | US20090017520 Process and Materials for Production of Glucosamine |
| 01/15/2009 | US20090017510 Enzymic method for the enantioselective reduction of keto compounds |
| 01/15/2009 | US20090017508 Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins |
| 01/15/2009 | US20090017502 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017501 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017500 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 01/15/2009 | US20090017499 Rank ligand-binding polypeptides |
| 01/15/2009 | US20090017498 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090017497 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 01/15/2009 | US20090017496 Co-expression of multiple protein chains or subunits |
| 01/15/2009 | US20090017495 Escherichia coli-derived vaccine and therapy against botulism |
| 01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/15/2009 | US20090017493 Gene SMS 02 |
| 01/15/2009 | US20090017492 SVPH1-26 DNA and polypeptides |
| 01/15/2009 | US20090017490 DNA Fragment Method for Producing Transformant for Protein Production and Utilization Thereof |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017468 Method of screening compound directly activating glycogen synthase |
| 01/15/2009 | US20090017467 COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV |
| 01/15/2009 | US20090017465 Compound Screening Using Cardiomyocytes |
| 01/15/2009 | US20090017454 Biosensors, method for obtaining the same and uses thereof |
| 01/15/2009 | US20090017451 Generation of Recombinant Genes in Saccharomyces Cerevisiae |
| 01/15/2009 | US20090017447 Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof |
| 01/15/2009 | US20090017162 Neutral cellulase catalytic core and method of producing same |
| 01/15/2009 | US20090017161 Gene encoding protein having trehalose synthesis-promoting activity and use thereof |
| 01/15/2009 | US20090017103 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017070 In vitro model for hepatitis c virion production |
| 01/15/2009 | US20090017068 Vaccines against West Nile Virus |
| 01/15/2009 | US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 01/15/2009 | US20090017061 Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan |
| 01/15/2009 | US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017045 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue |
| 01/15/2009 | US20090017044 Antibodies to the Human Prolactin Receptor |
| 01/15/2009 | US20090017042 Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798] |
| 01/15/2009 | US20090017039 SP35 Antibodies and uses thereof |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017034 inhibits thymic stromal lymphopoietin TSLP)-mediated lymphocyte stimulation; using these polypeptides as molecular weight markers that allow the estimation of the molecular weight of a protein or a fragmented protein |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017020 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017009 Method for the diagnosis and prognosis of malignant diseases |
| 01/15/2009 | US20090017008 Compositions and methods for altering bone density and bone patterning |
| 01/15/2009 | US20090016988 Modified Pore-Forming Protein Toxins and Use Thereof |
| 01/15/2009 | US20090016967 Compositions and methods for the treatment of respiratory disorders |
| 01/15/2009 | US20090016957 Polypeptides |
| 01/15/2009 | US20090014562 Spray Nozzle Apparatus and Method of Use |
| 01/15/2009 | US20090014384 Novel microorganism and process for treatment of organic solid matter using the microorganism |
| 01/15/2009 | US20090014332 Fractionation of Macro-Molecules Using Asymmetric Pulsed Field Electrophoresis |
| 01/15/2009 | DE10222714B4 Kofaktoren, die spezifisch mit dem Glukokortikoidrezeptor interagieren sowie Verfahren zu deren Identifizierung Cofactors, specifically interact with the glucocorticoid receptor and methods for their identification |
| 01/15/2009 | DE102007033104A1 Mittel enthaltend Proteasen aus Stenotrophomonas maltophilia Compositions containing proteases from Stenotrophomonas maltophilia |
| 01/15/2009 | DE102007032111A1 New subtilisin-type protease useful in products for cleaning textiles or hard surfaces |
| 01/15/2009 | CA2814246A1 Recurrent gene fusions in prostate cancer |
| 01/15/2009 | CA2729923A1 Dehydrated chitosan nanoparticles |
| 01/15/2009 | CA2693717A1 Immunology treatment for biofilms |
| 01/15/2009 | CA2693651A1 Bioactive peptides and method of using same |
| 01/15/2009 | CA2693646A1 Normal-tension glaucoma model and method for evaluation of test substances by using same |
| 01/15/2009 | CA2693467A1 Isopropyl alcohol-producing bacterium and method of producing isopropyl alcohol using the same |
| 01/15/2009 | CA2693438A1 Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens |
| 01/15/2009 | CA2693392A1 Novel compounds and their effects on feeding behaviour |
| 01/15/2009 | CA2692984A1 Allelic exchange mutagenesis in map |
| 01/15/2009 | CA2692813A1 Phosphatidic acid phosphatase homologs and use thereof |
| 01/15/2009 | CA2692802A1 Tnf superfamily collectin fusion proteins |
| 01/15/2009 | CA2692687A1 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
| 01/15/2009 | CA2692605A1 Novel esterases and their use |
| 01/15/2009 | CA2692037A1 Il-23 receptor antagonists and uses thereof |
| 01/15/2009 | CA2691051A1 A bile resistant bacillus composition secreting high levels of phytase |
| 01/15/2009 | CA2690730A1 Reversible sirna-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of huntington's disease |
| 01/15/2009 | CA2690629A1 Multipotent/pluripotent cells and methods |
| 01/15/2009 | CA2690317A1 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/15/2009 | CA2680741A1 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014772A2 Method for the diagnosis and prognosis of cancer |
| 01/14/2009 | EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2 |